Experimental drug targets protein leak in kidney patients
NCT ID NCT02682407
First seen Mar 31, 2026 · Last updated Jun 02, 2026 · Updated 11 times
Summary
This study tested an experimental drug called OMS721 (narsoplimab) in 31 people with four different kidney diseases that cause protein in the urine. The main goal was to check safety and see if the drug could reduce protein leakage. The trial was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LN are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Omeros Investigational Site
Denver, Colorado, 80230, United States
-
Omeros Investigational Site
Augusta, Georgia, 30909, United States
-
Omeros Investigational Site
Lawrenceville, Georgia, 30046, United States
-
Omeros Investigational Site
Evergreen Park, Illinois, 60805, United States
-
Omeros Investigational Site
Voorhees Township, New Jersey, 08043, United States
-
Omeros Investigational Site
Flushing, New York, 11355, United States
-
Omeros Investigational Site
San Antonio, Texas, 78215, United States
-
Omeros Investigational Site
Milwaukee, Wisconsin, 53226, United States
-
Omeros Investigational Site
Chai Wan, Hong Kong
-
Omeros Investigational Site
Hong Kong, Hong Kong
-
Omeros Investigational Site
Kowloon, Hong Kong
-
Omeros Investigational Site
Shatin, Hong Kong
Conditions
Explore the condition pages connected to this study.